TANYA JOHNSON: Open Payments
NPI 1306513031 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 47 payments from 24 companies in 2025. Trend: 2023 $572 · 2024 $3,008 · 2025 $1,879
Food & beverage: $1,879
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $350 |
| AstraZeneca Pharmaceuticals LP | 8 | $212 |
| Lilly USA, LLC | 5 | $168 |
| Hologic Sales and Service, LLC | 1 | $148 |
| Amgen Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| ViiV Healthcare Company | 1 | $121 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Stryker Corporation | 1 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
Products named: Ozempic, APTIMA, REPATHA, AREXVY, Wegovy, CABENUVA, BREZTRI, INSPIRE.
Industry payments across MD — which companies pay providers there.
